BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29198974)

  • 1. Low Acceptability of Certain Contraceptive Methods among Young Women.
    Hoopes AJ; Teal SB; Akers AY; Sheeder J
    J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):274-280. PubMed ID: 29198974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice.
    Paul R; Huysman BC; Maddipati R; Madden T
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S884.e1-S884.e9. PubMed ID: 31838124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated With Contraceptive Method Choice and Initiation in Adolescents and Young Women.
    Cohen R; Sheeder J; Kane M; Teal SB
    J Adolesc Health; 2017 Oct; 61(4):454-460. PubMed ID: 28712596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depot-medroxyprogesterone acetate contraception use among Salvadoran women: an in-depth analysis of attitudes and experiences.
    Cremer M; Ditzian L; April A; Peralta E; Klausner D; Podolsky R; Dierking E
    J Womens Health (Larchmt); 2011 Nov; 20(11):1751-6. PubMed ID: 21823919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An exploratory analysis of contraceptive method choice and symptoms of depression in adolescent females initiating prescription contraception.
    Francis J; Presser L; Malbon K; Braun-Courville D; Linares LO
    Contraception; 2015 Apr; 91(4):336-43. PubMed ID: 25553873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young men's awareness and knowledge of intrauterine devices in the United States.
    Marshall CJ; Gomez AM
    Contraception; 2015 Nov; 92(5):494-500. PubMed ID: 26169342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informing the introduction of contraceptive implants in the Pacific: a mixed methods study of contraceptive beliefs and behaviours in Tonga.
    Winn-Dix EA; Nathan SA; Rawstorne P
    Aust N Z J Public Health; 2016 Apr; 40(2):115-9. PubMed ID: 26713886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-month contraceptive continuation among women initiating short- and long-acting reversible contraceptives in North Kivu, Democratic Republic of the Congo.
    Casey SE; Cannon A; Mushagalusa Balikubirhi B; Muyisa JB; Amsalu R; Tsolka M
    PLoS One; 2017; 12(9):e0182744. PubMed ID: 28886016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual Desire and Hormonal Contraception.
    Boozalis A; Tutlam NT; Chrisman Robbins C; Peipert JF
    Obstet Gynecol; 2016 Mar; 127(3):563-572. PubMed ID: 26855094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraceptive method and self-reported HIV status among women in Malawi.
    Luster JE; Turner AN; Alkhalaileh D; Gallo MF
    Contraception; 2017 Jun; 95(6):558-563. PubMed ID: 28285153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of intrauterine contraception among women living with human immunodeficiency virus: a randomised clinical trial.
    Kakaire O; Tumwesigye NM; Byamugisha JK; Gemzell-Danielsson K
    Eur J Contracept Reprod Health Care; 2016 Jun; 21(3):220-6. PubMed ID: 26895345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve month follow-up of a contraceptive implant outreach service in rural Papua New Guinea.
    Gupta S; Mola G; Ramsay P; Jenkins G; Stein W; Bolnga J; Black K
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):213-218. PubMed ID: 28401563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Acting Reversible Contraceptive Attitudes and Acceptability in Adolescents and Young Adults: A Key to Patient-Centered Contraceptive Counseling.
    Richards MJ; Coleman-Minahan K; Sheeder J
    J Pediatr Adolesc Gynecol; 2020 Dec; 33(6):673-680. PubMed ID: 32860948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
    Krashin JW; Stuart GS; Garrett J; Spector H; Bryant AG; Charm S; Morse JE
    Obstet Gynecol; 2017 Jul; 130(1):109-117. PubMed ID: 28594755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.